Even though P53 was commonly recognized as a tumor suppressor, recently, it was reported to act as a critical mediator of chemotherapy drug-induced cancer stem cell activation via the WNT/β-catenin signaling pathway [20]. The gene discussed is TP53; the disease is neoplasm.